David Kim is currently the Head of Transactions for Business Development & Licensing at AstraZeneca and serves as a Board Member at 1st Biotherapeutics. With over 14 years of experience in the biotech and pharmaceutical industries, David has developed therapeutic area strategies and driven innovation through creative partnerships and acquisitions. David previously held positions as Senior Director of Business Development at Takeda, Director of Corporate Business Development at Shire, and Director of Business Development at Baxalta, among others. David's educational background includes a Bachelor of Arts in Economics from Northwestern University and an MBA from Columbia Business School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices